BOSTON, Feb. 23, 2017 /PRNewswire/ -- Visiomed, the French leader in medical grade connected devices and services since
As of February 2017, Visiomed is pleased to open the first North American BewellConnect Headquarters in the Back Bay neighborhood in downtown Boston, Massachusetts.
"BewellConnect is at the forefront of the telemedicine industry and we are excited to produce significant advances in the healthcare industry," says Olivier Hua, General Manager of Visiomed Group and CEO of BewellConnect Corp. "By creating alliances with the industry, establishing our presence in the region, we hope to change how people monitor their healthcare and improve their quality of life."
In the U.S., BewellConnect is informing the future of health care by providing patients with alternative solutions that aim to help reduce the number of visits to the doctor, lessen the probability of hospital readmission, curtail health risks, promote prevention through daily self-monitoring, and streamline the communication with medical professionals since the patient is more informed of their own body.
"As a company constantly shifting and breaking industry norms, we want to join forces with life science innovators in the US to change the treatment paradigm for people with chronic diseases and take the first steps towards self-monitoring medical devices," says Eric Sebban, CEO of Visiomed Group.
"I am happy to welcome Visiomed to Boston, and am pleased they have chosen our city for their first North American headquarters," said Mayor Martin J. Walsh. "Boston is a global leader in healthcare, and I look forward to including BewellConnect to our roster of innovative, forward-thinking and fast-growing companies."
"Visiomed works at the intersection of medical devices and digital health, and they are a welcome addition to our innovation economy," said Massachusetts Housing & Economic Development Secretary Jay Ash. "Telemedicine holds great promise for both improved patient outcomes and experience, and for meaningful savings in our health care system. We are glad to see Visiomed putting down roots in Massachusetts, and look forward to their future growth in the Commonwealth."
"We are pleased to welcome Visiomed to Massachusetts and congratulate them on opening the first North American BewellConnect Headquarters in Boston," said Robert K. Coughlin, President & CEO of MassBio. "We know that Visiomed will bring value to and benefit from our innovative healthcare ecosystem as they connect with new partners and work to improve patients' lives."
"Visiomed is developing technologies that have the potential both to improve patient care, and reduce health care costs through improved home monitoring and prevention," said Travis McCready, President & CEO of the Massachusetts Life Sciences Center. "We welcome the company's decision to advance these technologies here in Massachusetts, where innovation is transforming health care delivery."
About the VISIOMED GROUPFounded by Eric Sebban in 2007, VISIOMED GROUP is a company that specializes in next-generation medical electronics. The laboratory develops and markets innovative healthcare products in the promising areas of self-diagnosis for medical use and well-being. VISIOMED is also the inventor of the ThermoFlash®, the 1st contactless medical infrared thermometer. VISIOMED products combine innovation, technology and design to non-drug prevention and treatment solutions focusing on simplicity, comfort and well-being for users. In 2014, VISIOMED GROUP announced the launch of its "BewellConnect®" range of connected healthcare products, thus becoming the 1st medical electronics laboratory to penetrate the very promising market of the Internet of Things (IoT).
Based in Paris, France, VISIOMED GROUP relies on a team of 105 employees, with a sales force dedicated to commercialisation through pharmacies (OTC), to health professionals (hospitals, clinics, retirement homes) and, since late 2010, in retail shops. In 2015, the Group achieved a turnover of over €10M. VISIOMED GROUP is classified as an "Innovative Company" by Bpifrance.
VISIOMED GROUP was ranked 2nd in the national chart on the occasion of the 2014 edition of Deloitte In Extenso Technology Fast 50 and 2nd in Europe in the Health/Biotech/Pharma sector of the Deloitte Technology Fast 500. In 2016, VISIOMED GROUP won the ScaleUp Awards organised by KPMG and CroissancePlus and was ranked 1st among companies in the Health industry in the FW500 (FrenchWeb) ranking.
More information at www.visiomed-lab.com.
For more information, visit www.bewellconnect.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/visiomeds-bewellconnect-launches-presence-in-boston-300412704.html
SOURCE VISIOMED GROUP
Subscribe to our Free Newsletters!
Malaria is a dangerous disease with lethal consequences that requires protective measures for ...
Merkel cell carcinoma is a rare and a highly aggressive primary skin cancer that grows rapidly and ...
Vitrectomy is a surgical procedure performed to remove a part or whole of the vitreous humor ...View All